110 related articles for article (PubMed ID: 21174002)
21. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis.
Nagashima T; Okazaki H; Yudoh K; Matsuno H; Minota S
Arthritis Rheum; 2006 Feb; 54(2):579-86. PubMed ID: 16447234
[TBL] [Abstract][Full Text] [Related]
22. [Effects of fluvastatin on the activation of p38 mitogen-activated protein kinase in glomerular mesangial cells under high concentration of glucose].
Wang LH; Wu GL; Zhang LX; Huang XD; Li S
Yao Xue Xue Bao; 2009 Feb; 44(2):121-5. PubMed ID: 19408679
[TBL] [Abstract][Full Text] [Related]
23. Fluvastatin inhibits expression of the chemokine MDC/CCL22 induced by interferon-gamma in HaCaT cells, a human keratinocyte cell line.
Qi XF; Kim DH; Yoon YS; Li JH; Jin D; Teng YC; Kim SK; Lee KJ
Br J Pharmacol; 2009 Aug; 157(8):1441-50. PubMed ID: 19594754
[TBL] [Abstract][Full Text] [Related]
24. Effects of rosuvastatin on fibrinolytic system of human umbilical vein endothelial cells in vitro.
He F; Zhao J; Guo R; Liang Y
Am J Med Sci; 2014 Oct; 348(4):319-23. PubMed ID: 24694789
[TBL] [Abstract][Full Text] [Related]
25. Chronic fluvastatin treatment alters vascular contraction by inhibiting the Rho/Rho-kinase pathway.
Kansui Y; Fujii K; Goto K; Oniki H; Iida M
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):673-8. PubMed ID: 16895538
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of proliferation and signalling mechanisms in human lymphocytes by fluvastatin.
Hillyard DZ; Cameron AJ; McIntyre AH; Hadden MH; Marshall HE; Johnston N; Jardine AG
Clin Exp Pharmacol Physiol; 2002 Aug; 29(8):673-8. PubMed ID: 12099998
[TBL] [Abstract][Full Text] [Related]
27. Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery.
Sakamoto K; Murata T; Chuma H; Hori M; Ozaki H
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):327-33. PubMed ID: 15591221
[TBL] [Abstract][Full Text] [Related]
28. Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells.
Aoki C; Nakano A; Tanaka S; Yanagi K; Ohta S; Jojima T; Kasai K; Takekawa H; Hirata K; Hattori Y
Int J Cardiol; 2012 Apr; 156(1):55-61. PubMed ID: 21093076
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.
Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Nakamura H
Cancer Res; 2001 Jun; 61(12):4885-91. PubMed ID: 11406567
[TBL] [Abstract][Full Text] [Related]
30. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
[TBL] [Abstract][Full Text] [Related]
31. t-PA stimulates VEGF expression in endothelial cells via ERK2/p38 signaling pathways.
Duan P; Ni C
Pharmazie; 2014 Jan; 69(1):70-5. PubMed ID: 24601228
[TBL] [Abstract][Full Text] [Related]
32. Effects of statins on adhesion molecule expression in endothelial cells.
Dimitrova Y; Dunoyer-Geindre S; Reber G; Mach F; Kruithof EK; de Moerloose P
J Thromb Haemost; 2003 Nov; 1(11):2290-9. PubMed ID: 14629460
[TBL] [Abstract][Full Text] [Related]
33. RhoA-dependent PAI-1 gene expression induced in endothelial cells by monocyte adhesion mediates geranylgeranyl transferase I and Ca2+ signaling.
Sakamoto T; Ishibashi T; Sugimoto K; Sakamoto N; Ohkawara H; Niinuma M; Nagata K; Kamioka M; Sugimoto N; Watanabe A; Kurabayashi M; Takuwa Y; Maruyama Y
Atherosclerosis; 2007 Jul; 193(1):44-54. PubMed ID: 16973169
[TBL] [Abstract][Full Text] [Related]
34. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
[TBL] [Abstract][Full Text] [Related]
35. Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells.
Jaulmes A; Sansilvestri-Morel P; Rolland-Valognes G; Bernhardt F; Gaertner R; Lockhart BP; Cordi A; Wierzbicki M; Rupin A; Verbeuren TJ
Thromb Res; 2009 Sep; 124(4):439-46. PubMed ID: 19540572
[TBL] [Abstract][Full Text] [Related]
36. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
[TBL] [Abstract][Full Text] [Related]
37. Rac1/Cdc42 and RhoA GTPases antagonistically regulate chondrocyte proliferation, hypertrophy, and apoptosis.
Wang G; Beier F
J Bone Miner Res; 2005 Jun; 20(6):1022-31. PubMed ID: 15883643
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of lysophosphatidic acid-induced RhoA activation and tumor cell invasion by 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
Kusama T; Mukai M; Ayaki M; Imamura F; Tatsuta M; Matsumoto Y; Nakamura H; Inoue M
Int J Oncol; 2003 Oct; 23(4):1173-8. PubMed ID: 12964001
[TBL] [Abstract][Full Text] [Related]
40. Relevance of the mevalonate biosynthetic pathway in the regulation of bone marrow mesenchymal stromal cell-mediated effects on T-cell proliferation and B-cell survival.
Musso A; Zocchi MR; Poggi A
Haematologica; 2011 Jan; 96(1):16-23. PubMed ID: 20884711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
